Physician profile
Randall Thomas Parrish
NPI 1104898154
$4,674.40
in general payments reported to CMS, 2019-2025
18 companies · $783 in 2025
The $783 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,245 · 2020: $854 · 2021: $201 · 2022: $646 · 2023: $624 · 2024: $322 · 2025: $783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,612 · Entertainment: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,612.20 |
| Entertainment | $116.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $1,140.45 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $492.93 | 2022-2025 | Infuse |
| Coopervision INC. | $490.85 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Optos, INC. | $430.16 | 2019-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $411.24 | 2019-2025 | Tryptyr, Dailies Total1 |
| Dompe US, INC. | $312.42 | 2021-2024 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $278.79 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $221.35 | 2019-2020 | |
| Biotissue Holdings INC. | $160.24 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $121.66 | 2023 | Cequa |
| Maculogix, INC. | $105.02 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $99.93 | 2025 | Xdemvy |
| Ocular Therapeutix, INC. | $91.51 | 2022 | |
| Optovue, INC. | $90.33 | 2019 | |
| Lkc Technologies, INC. | $88.46 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $84.48 | 2024 | Tepezza |
| Visionix USA, INC | $35.18 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Parrish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.